Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Norvège (1)
Advocacy (policy advocacy, lobbying)
Biotech Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Representativeness of stakeholders
Health Technology Assessment (HTA) activities